LSTM’s health economists Professor Louis Niessen and Dr Jahangir Khan outline the importance for universal access to medicines in the control of neglected diseases, other major infections, and chronic diseases.
In an editorial in the journal The Lancet Professor Niessen and Dr Khan argue that strategies to make medicines more available and affordable are critical in increasing their use in low- and middle- income countries. There is a double burden of infectious and chronic diseases, while the awareness of the benefits of prevention and treatment has grown.
Their comment comes following the publication of the McMaster University-lead Prospective Urban Rural Epidemiology (PURE) study on the availability and costs of cardiovascular medicine across 18 countries. This landmark health economics study on the empirical costs of medicines with comparisons across both high- and low-income settings, shows that secondary prevention is unavailable and unaffordable in the surveyed 94,919 communities across the world. Professor Niessen and Dr Khan argue that its findings are important in the formulation of policies on universal health coverage and the mobilisation and use of resources in relation to NTDs, and infectious and chronic diseases.
They state that it is unlikely that surplus household income is available for prevention. Household expenditures relate to all major health events – including strokes, infarctions, neglected tropical diseases, major infections, injuries, and cancers. Many households become poor due to income loss from illness. Health safety nets such as insurance in advancing systems provide broader coverages. In fragile communities societal safety nets may cover all types of events as food shortages and disasters. Secondly, they explain that use of medicines is influenced by general awareness, health literacy, service quality, and the quality of workers. This is all important as increased availability may lead to misuse.
They acknowledge that universal access to medicine promotion has to address these multiple obstacles in the provision of appropriate care to communities. At national level, options for policy-makers are price control measures, price management of generic medicines and promotion of market entry through flexible TRIPS arrangements and licensing, and internal reference pricing of generic. An increase in international co-ordinated actions, such as mass production of low-cost antiretroviral drugs and the mass drug provision in the control of neglected tropical diseases is needed. Low cost treatments are possible for many conditions through mass production.
The Latest on: Universal access to medicines
[google_news title=”” keyword=”Universal access to medicines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Universal access to medicines
- Sanders to seek gavel of Senate health committeeon November 17, 2022 at 12:01 pm
“As chairman of the committee, he will focus on universal health care, lowering the cost of prescription drugs, increasing access to higher education, and protecting workers’ rights on the job,” ...
- Medicine and Mortality in Mali: one health heroine's work to improve community healthon November 16, 2022 at 1:42 am
She began her medical career by attending the University of Bamako's Faculty of Medicine, Pharmacy ... so that every human being can have the right to access health care because we firmly believe that ...
- StatCan data points to imbalance in medication accesson November 14, 2022 at 5:01 am
The agency’s study titled “Pharmaceutical access and use during the pandemic” found that because of financial hardships or increased out-of-pocket expenditures, this absence of coverage occasionally ...
- Universal Masking in School Works. New Data Shows How Wellon November 9, 2022 at 3:30 pm
A new report from Boston schools shows that universal masking for kids reduces the spread of COVID-19 and keeps kids in school ...
- US to boost medication access to tackle opioid overdose crisison November 8, 2022 at 4:35 pm
But providing universal access to medications requires sweeping reforms to remove ... “There is enormous stigma around the use of these [medication] drugs,” said Mark Parrino, president of the ...
- COVID-19 'test to treat' sites less accessible to many marginalized communitieson November 8, 2022 at 4:00 pm
A new study from investigators at Brigham and Women's Hospital, a founding member of Mass General Brigham, the University of Virginia School of Medicine, and the University of Pittsburgh, finds that ...
- DOH to provide medicines, aid for typhoon victims in Maguindanaoon November 8, 2022 at 1:27 am
The Department of Health (DOH) on Tuesday said that it would provide medicines and other commodities in Maguindanao to aid and implement primary health care for typhoon victims ...
- Low- and middle-income countries struggle to provide health care to some, while others get too much medicineon November 2, 2022 at 9:35 am
Access to quality health care is a fundamental ... the World Health Organization and many nations promote is to provide universal health coverage, like Australia's Medicare system.
- LSTM's health economists call for strategies for universal access to medicineson October 20, 2022 at 5:00 pm
LSTM's health economists Professor Louis Niessen and Dr Jahangir Khan outline the importance for universal access to medicines in the control of neglected diseases, other major infections, and chronic ...
- 3 in 10 uninsured Americans with diabetes may ration insulin: Studyon October 19, 2022 at 3:04 pm
"Universal access to insulin, without cost barriers ... published in the Annals of Internal Medicine on Monday. Overall, researchers found that 16.5% of adults with diabetes who use insulin ...
via Bing News